A deficiency of reduced glutathione in erythrocytes of freshly shed blood (1) (2) (3) (4) or in erythrocytes exposed to certain chemical compounds (5) has been associated with shorter red cell survival and, in most cases, with the accumulation of oxidation products of hemoglobin, including methemoglobin, sulfhemoglobin, and Heinz bodies. Studies of "primaquine-sensitive" hemolytic disease have emphasized as a characteristic feature an "unstable" reduced glutathione (GSH) in the red cells, attributed to limited availability of reduced TPN (TPNH), the result, in turn, of a deficiency of the enzyme, glucose-6-phosphate dehydrogenase -(G6PD). Despite extensive studies of G6PD deficiency, it is still uncertain whether the observations on reduced glutathione are of pathogenetic significance or are incidental. There is even less information on the role of glutathione in certain cases of congenital methemoglobinemia (1) and in hemolytic disease with (3, 4, 6) or without (2) inclusion bodies, which have been associated with abnormalities of glutathione. Although these cases may suggest that reduced glutathione in the erythrocyte may be the final common pathway for various disorders affecting oxidative hemolysis, the evidence conflicts as to how, if at all, glutathione protects the healthy erythrocyte from oxidative hemolysis.
Mills (7) (8) (9) and Randall (7), after studies of rat blood, concluded that GSH protects hemoglobin from deleterious oxidative agents only in the presence of an additional factor, an enzyme they termed glutathione peroxidase. Studies of * Submitted for publication November 9, 1962;  accepted September 12, 1963. This investigation was supported by a research grant (AM-04489) and a graduate training grant (T1 AM-5098) from the National Institute of Arthritis and Metabolic Diseases, U. S. Public Health Service, Bethesda, Md. human erythrocytes by Allen and Jandl (10) led these authors to conclude that GSH per se protects hemoglobin from oxidation and that no additional factors are required; conversely, Szeinberg and Marks (11) found that GSH affords no protection to human hemoglobin against oxidative changes. The earlier report of Foulkes and Lemberg (12) that GSH might oxidize hemoglobin, along with the studies by Szeinberg and Marks (11) and Allen and Jandl (10) , casts doubt on the applicability to humans of the concept (13, 14) , based on studies of rat blood (7, 8) , that an adequate amount of reduced glutathione and the enzyme glutathione peroxidase together protect hemoglobin from oxidative breakdown.
Our experiments demonstrate, by the use of erythrocytes and hemoglobin from human subjects, that in an in vitro system GSH can protect hemoglobin from oxidizing agents and that this protection is dependent upon a nonhemoglobin protein factor of erythrocytes, adduced to be glutathione peroxidase. We further present an experimental basis for reconciliation of the preceding contradictory reports concerning the role of glutathione.
Methods Venous blood from hematologically normal and apparently healthy adults was anticoagulated with heparin.
Plasma, buffy coat, and uppermost erythrocytes were removed after prompt centrifugation at 5°C . The remaining red cells were washed three times each with 4 vol of cold Krebs-Ringer phosphate buffer (7, 8) Preparation of hemoglobin solution. Sufficient deionized water was added to washed erythrocytes to hemolyze them and to yield about 8 ml of solution with a hemoglobin concentration of about 10 g per 100 ml. To this was added 15 g of diethylaminoethyl (DEAE) cellulose from which excess water had been removed. DEAE had been prepared according to the method of Hennessey, Haffner, and Gabrio (15; also Waltersdorph and Huennekens, 16), except for the addition of a final series of washes with deionized water, continued until the supernatant fluid gave a negative phosphate test with silver nitrate. After the mixture of DEAE cellulose and hemolysate was stirred for about 5 minutes, the hemoglobin solution was separated f rom the cellulose by suction, through the use of a coarse, sintered glass funnel. The filtrate, containing about 8 g of hemoglobin per 100 ml, was the hemoglobin solution employed in these experiments; it was kept cold and used within 48 hours of the time of preparation. The hemoglobin solution was found to be devoid of catalase, G6PD, pyruvate kinase, and glutathione peroxidase activities and to contain carbonic anhydrase activity, each assayed by techniques described below. The whole hemolysate contained all of these enzymatic activities. The nonhemoglobin protein solution, described below, contained all of these activities except carbonic anhydrase.
Preparation of nonhemoglobin protein solution. After extraction of the hemoglobin solution by suction, the cellulose was washed three times in a total of 4,500 ml of cold, deionized water. Excess water was expressed, and the cellulose was treated with 4 ml of 0.4 M phosphate buffer, pH 7.1. The eluate was separated on a coarse, sintered glass funnel and then was used to reextract the cellulose. The resulting yellow solution was termed the nonhemoglobin protein (NHP) solution.
The ratio of the absorbance at 280 mAt to that at the Soret band (420 m/is) was 2:1 for the NHP solution, Chemical determinations and enzyme assays. Reduced glutathione was determined by the method used by Mills (9) based on principles outlined by Boyer (17) and also by the technique of Grunert and Phillips (18) as modified by Beutler (19) . Oxidized glutathione was determined as reduced glutathione by the same technique, after electrolytic reduction by the method of Dohan and Woodward (20) . 2 Sigma Chemical Co., St. Louis, Mo.
Samples for the determination of hemoglobin pigment were placed in 25-X 40-mm glass tubes and subjected to 20 kc ultrasound at 4 amp power input at cavitary resonance for 5 seconds.3 This insured complete hemolysis and did not affect the proportion of hemoglobin derivatives. The samples, after centrifugation at 2,000 X g for 5 minutes, were clear.
Methemoglobin, sulfhemoglobin, oxyhemoglobin, and total hemoglobin were determined by the method of Evelyn and Malloy (21) . Results are expressed as per cent of the total hemoglobin at time zero. "Precipitated hemoglobin" was calculated by subtracting the measured total hemoglobin from the hemoglobin at time zero. In one experiment the precipitated hemoglobin was collected and weighed.
Catalase was determined by the method used by Takahara and co-workers (22) , except that the determinations were carried out at 200 C. Glucose-6-phosphate dehydrogenase was determined in the manner of Kornberg and Horecker (23) as modified by Marks, Szeinberg, and Banks (24) . Pyruvate kinase was determined by the method of Bucher and Pfleiderer (25) as modified by Valentine, Tanaka, and Miwa (26) . Glutathione peroxidase was determined by a modification of method number two of Mills (9) . Carbonic anhydrase was determined by the technique of Wilbur and Anderson (27) . Glutathione reductase was determined by the mode of Schrier and co-workers (28) .
The data were treated as nonindependent variables. A p value of less than 0.05 was considered to be significant (29) .
Results
Effect of ascorbic acid on the formation of sulfhemoglobin in washed erythrocytes, whole hemolysates, and hemoglobin solutions. The formation of oxidative derivatives of hemoglobin in intact erythrocytes, whole hemolysates, and hemoglobin solutions was zero in 2 hours. Ascorbic acid or acetylphenylhydrazine was therefore added to the incubation flasks to accelerate these oxidative changes, against which the effects of various compounds could be measured.
The augmentation of sulfhemoglobin formation produced by the addition of ascorbic acid was greatest when the substrate was hemoglobin solution, least when the substrate was intact erythrocytes, and intermediate in the case of whole hemolysate (Table I) .
Effect of GSH on the formation of sulfhemoglobin in whole hemolysates and hemoglobin solutions incubated with ascorbic acid. GSH had a significant protective effect against the formation ,3Branson Instruments, Stamford, Conn. The flasks containing washed erythrocytes also contained enough Krebs-Ringer phosphate buffer to bring the volume to 50 ml. The flasks containing whole hemolysate and those containing hemoglobin solution also contained EDTA, 3.42 X 10-4 M, added in 0.15 M sodium chloride; 2 ml of 0.4 M phosphate buffer (pH 7.40); and sufficient water and 0.15 M sodium chloride to bring the volume to 8 ml and render it isotonic. Erlenmeyer flasks (125 ml) were used for the experiment with whole cells. Siliconized Erlenmeyer flasks (50 ml) were used for the experiments with whole hemolysates and hemoglobin solutions. Incubations were carried out at 370 C in a Dubnoff metabolic shaker at about 100 oscillations per minute. These were single experiments.
PROTECTION OF HEMOGLOBIN FROM OXIDATION
of sulfhemoglobin in whole hemolysates but no effect in hemoglobin solutions (Table II) .
Effect of ascorbic acid on the formation of oxidative derivatives of hemoglobin in washed red cells. The addition of sodium azide, a catalase solution; EDTA, 3.42 X 10-M, added in 0.15 M sodium chloride. These preceding reagents were added to all flasks. In addition each flask contained 2 ml of 0.4 M phosphate buffer (pH 7.40) and sufficient water and 0.15 M sodium chloride to bring the final volume to 8 ml and render it isotonic: Siliconized Erlenmeyer flasks (50 ml) were used for the incubation, which was carried out at 370 C in a Dubnoff metabolic shaker at about 100 oscillations per minute. These were single experiments.
inhibitor, increased the formation of methemoglobin and sulfhemoglobin in the presence of ascorbic acid (p < 0.05) (Table III) . If, in addition to sodium azide, glucose was added, the formation of oxidative derivatives was reduced significantly (p < 0.05). There was no significant loss of hemoglobin in these experiments.
Effect of GSH on the formation of oxidative derivatives of hemoglobin in whole hemolysates. In the presence of either ascorbic acid or acetyl- phenylhydrazine, the formation of methemoglobin and sulfhemoglobin was significantly less and the preservation of oxyhemoglobin was significantly greater when GSH was added to the incubation mixtures (Tables IV and V) .
Effect of GSH and NHP on the formation of oxidative derivatives of hemoglobin in hemoglobin solutions. Hemoglobin solutions differed from whole hemolysates in that they lacked NHP. In hemoglobin solutions incubated with ascorbic acid, the addition of GSH without NHP provided some protection against the formation of methemoglobin (p < 0.05) but none against the formation of sulfhemoglobin or precipitated hemoglobin. GSH alone resulted in no increase in the preservation of oxyhemoglobin. NHP provided a significant (p < 0.05) reduction in the amount of sulfhemoglob-n formed and in the amount of oxyhemoglobin preserved but did not affect the amount of hemoglobin precipitated. The combination of GSH and NHP was no more effective than GSH alone in protecting against the formation of methemoglobin, but the combination was more effective than GSH in protecting against the NHP, which contained only 1.8 ml. Flasks also contained sufficient 0.15 M sodium chloride and water to bring the final volume to 8 ml and render the solutions isotonic. The incubation was carried out in cellulose nitrate ultracentrifuge tubes that were dried to constant weight before the experiment. The tubes were incubated at 370 C in a Dubnoff metabolic shaker at about 100 oscillations per minute. At the end of the incubation period, the tubes were centrifuged at 144,000 X g for 1 hour. The supernatant solution was decanted, the precipitate was washed in water, and the centrifugation was repeated. The tubes were again dried to constant weight in a desiccator. formation of sulfhemoglobin and. precipitated hemoglobin and in the preservation of oxyhemoglobin (Table VI) . Dialysis of NHP against 1,000 vol of deionized water at 80 C for 36 hours did not remove its protective effect; however, it was inactivated by standing 72 hours at 220 C.
In solutions incubated with acetylphenylhydrazine, GSH alone provided no protection. NHP alone provided some protection against the formation of methemoglobin and sulfhemoglobin and in the preservation of oxyhemoglobin (p < 0.05) but did not protect against the formation of "precipitated" hemoglobin. The combination of GSH with NHP provided more protection than NHP alone against the formation of methemoglobin, sulfhemoglobin, and "precipitated" hemoglobin and was more effective in preserving oxyhemoglobin (p < 0.05) ( Table VII) .
Effect of GSH and NHP on the formation of precipitated hemoglobin in hemoglobin solutions incubated zwnith acetylphenylhydrazine. In a single experiment, in which the amount of hemoglobin precipitated was actually weighed, GSH had some effect in reducing the amount of hemoglobin precipitated, but NHP alone actually seemed to increase the amount of hemoglobin precipitated; when both GSH and NHP were added, no hemoglobin was precipitated (Table VIII) .
Effect of NHP on GSH in the presence of hydrogen peroxide. Hydrogen peroxide alone was found to produce only a slow fall in the concentration of GSH in solution, nor was this altered by the addition of either NHP or sodium azide individually (Figure 1 ). The addition, however, of both NHP and sodium azide at the same time accelerated the disappearance of GSH in the presence of hydrogen peroxide. The rate of fall of GSH concentration in the tubes with NHP and sodium azide was significantly different from the control tubes at 1, 2, and 3 minutes (p < 0.001). The conversion of GSH to its oxidized disulfide form (GSSG) was measured in a single similar experiment. Six and one-half /moles of GSH and' 0.35 /mole of GSSG were present at the beginning of the reaction. Eight minutes later there were 0.7 umole of GSH and 3.2 umoles of GSSG (Figure 2) .
The factor in the NHP solution which catalyzed this reaction was not removed by dialysis against 1,000 vol of deionized water at 40 C for 36 hours; it was, however, inactivated by incubation at 700 C for 1 hour or at 220 C for 72 hours or by the addition of 1 vol of 10% trichloroacetic acid Presence of protective activity in various types of hemoglobin preparations. Crystals of hemoglobin, prepared by the. method of Drabkin (30) , substituted for NHP solution in the conversion of GSH to GSSG in the presence of hydrogen peroxide and azide (Table IX) . In contrast, the hemoglobin solution prepared by the method outlined in this report was free of the protective activity (Tables VI-VIII) (Table III) in which methemoglobin and sulfhemoglobin were measured. Finally, the indirect determination of precipitated hemoglobin obtained by subtracting the measured total hemoglobin from the hemoglobin at time zero must be considered to be only semiquantitative. Recognizing these limitations of our studies, our measurements of methemoglobin, sulfhemoglobin, oxyhemoglobin, and total hemoglobin provide as good a measure of the oxidation of hemoglobin as is presently available.
Hemoglobin, when exposed to air in vitro, will form the oxidation products, methemoglobin and sulfhemoglobin, and will eventually precipitate (31) . Among the mechanisms for prevention of this occurrence in the normal erythrocyte in vivo (13) , despite the presence of oxygen in the blood, are systems involving methemoglobin reductase (32, 33) and, possibly, catalase. Catalase can protect hemoglobin from oxidation in vitro (12); this can also be deduced from the consequence of its inhibition with azide in vitro ( Figure 1 ).
However, the reality and importance of this protection in vivo may be questioned for these reasons: 1) small amounts of hydrogen peroxide delivered continuously in vitro will not oxidize hemoglobin despite the absence of normal catalase activity until GSH is removed (34); 2) individuals with acatalasemia have not been reported to have methemoglobinemia or sulfhemoglobinemia (35, 36) ; and 3) oxidation products of hemoglobin may accumulate in diseases of people with normal erythrocytic catalase and methemoglobinreductase but with low or unstable erythrocytic GSH (37) . The existence of an additional mechanism, protecting hemoglobin from oxidation when catalase is inhibited and requiring both GSH and an erythrocyte enzyme, was suggested by Mills in studies of bovine and rat blood (7, 8) and has been confirmed by our observations in humans.
The report of Allen and Jandl (10) that GSH, without the addition of other factors, would protect crystalline human hemoglobin from oxidation may be reconciled with the findings reported here. We have found that hemoglobin prepared as described by Drabkin (30) We propose that the action of the enzymatic system in the in vitro protection of hemoglobin from oxidation might be as follows. In the presence of agents capable of oxidizing either hemoglobin or GSH, the enzyme enables preferential oxidation of GSH, sparing the hemoglobin. GSSG would then be reduced by the previously described pathway (5) involving glutathione reductase and G6PD for the generation of TPNH.
Thus, four lesions in the glutathione pathway might interfere with the protection of hemoglobin against oxidation. The clinical occurrence of three of these has been described: 1) G6PD deficiency (41), 2) deficiency of glutathione reductase (42) 3. The existence of a glutathione peroxidase activity in human erythrocytes has been demonstrated. This supports its earlier demonstration in erythrocytes of lower mammals. 4 . We suggest that in the presence of oxidizing agents, in vitro, glutathione peroxidase mediates the preferential oxidation of glutathione rather than of hemoglobin, as might otherwise occur; and that Heinz bodies or met-sulf hemoglobin formation in vivo may result if there is a defect in this enzyme, even when the production of reduced glutathione is intact.
